HROWHARROW, INC.

Nasdaq harrowinc.com


$ 15.88 $ -0.10 (-0.66 %)    

Thursday, 16-May-2024 14:02:59 EDT
QQQ $ 453.30 $ -0.17 (-0.04 %)
DIA $ 399.76 $ 0.13 (0.03 %)
SPY $ 529.92 $ -0.01 (-0 %)
TLT $ 92.11 $ -0.28 (-0.3 %)
GLD $ 220.40 $ 0.39 (0.18 %)
$ 15.925
$ 15.98
$ 15.84 x 100
$ 15.90 x 100
$ 15.87 - $ 16.34
$ 7.60 - $ 24.19
1,013,789
na
564.85M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-19-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-08-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-21-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-12-2016 03-31-2016 10-Q
34 03-23-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-13-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 craig-hallum-maintains-buy-on-harrow-raises-price-target-to-26

Craig-Hallum maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $24 to $26.

 b-riley-securities-reiterates-buy-on-harrow-raises-price-target-to-29

B. Riley Securities analyst Sahil Kazmi reiterates Harrow (NASDAQ:HROW) with a Buy and raises the price target from $26 to $29.

 harrow-health-q1-2024-adj-eps-028-misses-020-estimate-sales-34600m-miss-37268m-estimate

Harrow Health (NASDAQ:HROW) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.2...

 craig-hallum-initiates-coverage-on-harrow-with-buy-rating-announces-price-target-of-24

Craig-Hallum initiates coverage on Harrow (NASDAQ:HROW) with a Buy rating and announces Price Target of $24.

 insiders-buying-greenwich-lifesciences-and-2-other-stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

 why-taysha-gene-therapies-shares-are-trading-higher-by-around-27-here-are-20-stocks-moving-premarket

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a y...

 harrow-posts-weak-q4-results-joins-terawulf-nasdaq-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

 harrow-health-q4-adj-eps-020-misses-004-estimate-sales-3635m-miss-3786m-estimate

Harrow Health (NASDAQ:HROW) reported quarterly Adj losses of $(0.20) per share which missed the analyst consensus estimate of $...

 harrow-q4-earnings-insights
Harrow: Q4 Earnings Insights
03/19/2024 21:40:06

 earnings-scheduled-for-march-19-2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION